Riskpilot← Back to searchSign inGet full accessMedAssist ApS
APSActiveCVR 37377066Murervej 7B, 1. tvGeneral medical practice activities · NACE 8621Est. 201662 employeeswww.medassist.dk
Revenue 2025
DKK 60,3M
+27% vs 2024
EBITDA margin
30.0%
+53% vs 2024
Equity ratio
67.7%
Financial strength
Net profit 2025
DKK 13,7M
+53% vs 2024
| Revenue | DKK 60,3M | +27% |
| EBITDA | DKK 18,1M | +53% |
| Net profit | DKK 13,7M | +53% |
| Total assets | DKK 24,5M | +37% |
| Equity | DKK 16,6M | +40% |
| Employees | 62 | — |
Legal name
MedAssist ApS
CVR number
37377066
Legal form
Anpartsselskab
NACE code
8621 · General medical practice activities
Founded
18. januar 2016
Share capital
DKK 100.000
Employees
62 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2025-06-30
Financial year
January – December
Signatory rights
Selskabet tegnes af den samlede bestyrelse eller af direktøren i forening med bestyrelsesformanden.
Company purpose
Selskabets formål er at levere ydelser af høj kvalitet inden for områderne: "Bemanding og kontrol" inden for sundhedssektoren, herunder drift af lægeklinikker.
Address
Murervej 7B, 1. tv
Phone
+4572119091
Email
nils@medassist.dk
Website
www.medassist.dk
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.191 | 13.503 | 19.449 | 28.154 | 33.346 | 27.950 | 37.975 | 47.451 | 60.282 |
| Staff expenses | -3.014 | -13.494 | -18.047 | -24.132 | -26.967 | -22.861 | -29.631 | -35.649 | -42.206 |
| EBITDA | -1.823 | 10 | 1.402 | 4.022 | 6.379 | 5.090 | 8.343 | 11.802 | 18.076 |
| Depreciation & amort. | -0 | -6 | -88 | -189 | -254 | -263 | -306 | -446 | -576 |
| EBIT | -1.823 | 3 | 1.314 | 3.834 | 6.125 | 4.827 | 8.037 | 11.356 | 17.500 |
| Net financials | -11 | -3 | -38 | -22 | -64 | -68 | -2 | 125 | 110 |
| Profit before tax | -1.834 | 0 | 1.276 | 3.812 | 6.060 | 4.759 | 8.035 | 11.481 | 17.610 |
| Tax | -194 | -0 | 92 | 841 | 1.333 | 1.047 | 1.819 | 2.527 | 3.883 |
| Net profit | -1.640 | 0 | 1.184 | 2.971 | 4.727 | 3.712 | 6.216 | 8.955 | 13.727 |
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Total assets | 1.290 | 2.851 | 3.442 | 9.528 | 11.801 | 8.975 | 13.412 | 17.858 | 24.548 |
| Equity | 51 | 105 | 1.289 | 3.971 | 6.098 | 5.610 | 8.527 | 11.881 | 16.608 |
| Long-term debt | 65 | 163 | 0 | 0 | 0 | 0 | 0 | 2.522 | 3.954 |
| Short-term debt | 1.174 | 2.584 | 2.153 | 5.541 | 5.703 | 3.365 | 4.795 | 3.360 | 3.962 |
| Total debt | 1.239 | 2.746 | 2.153 | 5.541 | 5.703 | 3.365 | 4.795 | 5.882 | 7.916 |
EBITDA margin
30.0%
This company
15.8%
Market median
+90% vs market
20172025
Equity ratio
67.7%
This company
38.2%
Market median
+77% vs market
20172025
Return on equity
82.7%
This company
18.4%
Market median
+349% vs market
20172025
Net profit margin
22.8%
This company
8.1%
Market median
+181% vs market
20172025
Asset turnover
2.46×
This company
1.12×
Market median
+120% vs market
20172025
Debt / equity
0.48×
This company
0.62×
Market median
+23% vs market
20172025
- Annual report 2025Filed via CVR / Virk · Period 2024-07-01 – 2025-06-30
- Annual report 2024Filed via CVR / Virk · Period 2023-07-01 – 2024-06-30
- Annual report 2023Filed via CVR / Virk · Period 2022-07-01 – 2023-06-30
- Annual report 2022Filed via CVR / Virk · Period 2021-07-01 – 2022-06-30
- Annual report 2021Filed via CVR / Virk · Period 2020-07-01 – 2021-06-30
- Annual report 2020Filed via CVR / Virk · Period 2019-07-01 – 2020-06-30
- Annual report 2019Filed via CVR / Virk · Period 2018-07-01 – 2019-06-30
- Annual report 2018Filed via CVR / Virk · Period 2017-07-01 – 2018-06-30
- Annual report 2017Filed via CVR / Virk · Period 2016-01-18 – 2017-06-30
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
NB Management | Management | 2016 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2016 | — | — | |
| Board of Directors | 2016 | — | — | |
| Board of Directors | 2016 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
CEMMN ApS | Company | 50.0% | 50.0% | 2016 |
RAHR & RAHR EJENDOMS- OG INVESTERINGSSELSKAB ApS. ESBJERG | Company | 15.0% | 15.0% | 2016 |
BACCHUS ESBJERG ApS | Company | 15.0% | 15.0% | 2016 |
Emergenza ApS | Company | 10.0% | 10.0% | 2016 |
| Individual | 5.0% | 5.0% | 2017 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
RAHR & RAHR EJENDOMS- OG INVESTERINGSSELSKAB ApS. ESBJERG
MedAssist ApS Board members of MedAssist ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Nils Birger Høgalmen | Management | 0 companies |
| Jens Ole Kristensen | Chairman | 0 companies |
| Lauge Rahr | Board of Directors | 0 companies |
| Marianne Kierkegaard Kristensen | Board of Directors | 0 companies |